Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 289

1.

Treatment of Hodgkin lymphoma: a 50-year perspective.

Canellos GP, Rosenberg SA, Friedberg JW, Lister TA, Devita VT.

J Clin Oncol. 2014 Jan 20;32(3):163-8. doi: 10.1200/JCO.2013.53.1194. No abstract available.

PMID:
24441526
[PubMed - indexed for MEDLINE]
2.

Treatment for favorable localized Hodgkin lymphoma: the final answer is awaited.

Canellos GP.

Oncology (Williston Park). 2012 Dec;26(12):1199-200, 1202. No abstract available.

PMID:
23413601
[PubMed - indexed for MEDLINE]
Free Article
3.

Brentuximab vedotin and panobinostat: new drugs for Hodgkin's lymphoma--can they make one of medical oncology's chemotherapy success stories more successful?

Canellos GP.

J Clin Oncol. 2012 Jun 20;30(18):2171-2. doi: 10.1200/JCO.2011.39.6416. Epub 2012 Apr 30. No abstract available.

PMID:
22547611
[PubMed - indexed for MEDLINE]
Free Article
4.

Interim [(18)F]fluorodeoxyglucose positron emission tomography imaging in stage I-II non-bulky Hodgkin lymphoma: would using combined positron emission tomography and computed tomography criteria better predict response than each test alone?

Kostakoglu L, Schöder H, Johnson JL, Hall NC, Schwartz LH, Straus DJ, LaCasce AS, Jung SH, Bartlett NL, Canellos GP, Cheson BD; Cancer Leukemia Group B.

Leuk Lymphoma. 2012 Nov;53(11):2143-50. doi: 10.3109/10428194.2012.676173. Epub 2012 Aug 28.

PMID:
22421007
[PubMed - indexed for MEDLINE]
5.

Can low-risk, early-stage patients with Hodgkin lymphoma be spared radiotherapy?

Cote GM, Canellos GP.

Curr Hematol Malig Rep. 2011 Sep;6(3):180-6. doi: 10.1007/s11899-011-0088-8. Review.

PMID:
21503634
[PubMed - indexed for MEDLINE]
6.

Doxorubicin, vinblastine, and gemcitabine (CALGB 50203) for stage I/II nonbulky Hodgkin lymphoma: pretreatment prognostic factors and interim PET.

Straus DJ, Johnson JL, LaCasce AS, Bartlett NL, Kostakoglu L, Hsi ED, Schöder H, Hall NC, Jung SH, Canellos GP, Schwartz LH, Takvorian RW, Juweid ME, Cheson BD; Cancer and Leukemia Group B.

Blood. 2011 May 19;117(20):5314-20. doi: 10.1182/blood-2010-10-314260. Epub 2011 Feb 25.

PMID:
21355087
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Hematology in 2010: New therapies and standard of care in oncology.

DeVita VT Jr, Canellos GP.

Nat Rev Clin Oncol. 2011 Feb;8(2):67-8. doi: 10.1038/nrclinonc.2010.221. Review. Erratum in: Nat Rev Clin Oncol. 2011 Jul;8(7):384.

PMID:
21278770
[PubMed - indexed for MEDLINE]
8.

End-of-treatment but not interim PET scan predicts outcome in nonbulky limited-stage Hodgkin's lymphoma.

Barnes JA, LaCasce AS, Zukotynski K, Israel D, Feng Y, Neuberg D, Toomey CE, Hochberg EP, Canellos GP, Abramson JS.

Ann Oncol. 2011 Apr;22(4):910-5. doi: 10.1093/annonc/mdq549. Epub 2010 Oct 15.

PMID:
20952598
[PubMed - indexed for MEDLINE]
Free Article
9.

Treatment of favorable, limited-stage Hodgkin's lymphoma with chemotherapy without consolidation by radiation therapy.

Canellos GP, Abramson JS, Fisher DC, LaCasce AS.

J Clin Oncol. 2010 Mar 20;28(9):1611-5. doi: 10.1200/JCO.2009.25.3260. Epub 2010 Feb 16.

PMID:
20159818
[PubMed - indexed for MEDLINE]
Free Article
10.

Is chemotherapy alone for early Hodgkin lymphoma an emerging therapeutic option?

Canellos GP.

Oncologist. 2009 Dec;14(12):1167-8. doi: 10.1634/theoncologist.2009-0288. Epub 2009 Dec 11. No abstract available.

PMID:
20008306
[PubMed - indexed for MEDLINE]
Free Article
11.

Long-term follow-up of survival in Hodgkin's lymphoma.

Canellos GP, Niedzwiecki D, Johnson JL.

N Engl J Med. 2009 Dec 10;361(24):2390-1. doi: 10.1056/NEJMc0906731. No abstract available.

PMID:
20007568
[PubMed - indexed for MEDLINE]
Free Article
12.

What is the appropriate systemic chemotherapy for lymphocyte-predominant Hodgkin's lymphoma?

Canellos GP, Mauch P.

J Clin Oncol. 2010 Jan 1;28(1):e8. doi: 10.1200/JCO.2009.26.3293. Epub 2009 Nov 23. No abstract available.

PMID:
19933898
[PubMed - indexed for MEDLINE]
Free Article
13.

Immunochemotherapy and autologous stem-cell transplantation for untreated patients with mantle-cell lymphoma: CALGB 59909.

Damon LE, Johnson JL, Niedzwiecki D, Cheson BD, Hurd DD, Bartlett NL, Lacasce AS, Blum KA, Byrd JC, Kelly M, Stock W, Linker CA, Canellos GP.

J Clin Oncol. 2009 Dec 20;27(36):6101-8. doi: 10.1200/JCO.2009.22.2554. Epub 2009 Nov 16.

PMID:
19917845
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Improved survival in lymphoma patients receiving sirolimus for graft-versus-host disease prophylaxis after allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning.

Armand P, Gannamaneni S, Kim HT, Cutler CS, Ho VT, Koreth J, Alyea EP, LaCasce AS, Jacobsen ED, Fisher DC, Brown JR, Canellos GP, Freedman AS, Soiffer RJ, Antin JH.

J Clin Oncol. 2008 Dec 10;26(35):5767-74. doi: 10.1200/JCO.2008.17.7279. Epub 2008 Nov 10.

PMID:
19001324
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

What constitutes "improved prognosis"?

Canellos GP.

J Clin Oncol. 2008 Apr 20;26(12):1913-4. doi: 10.1200/JCO.2007.13.8172. No abstract available.

PMID:
18421041
[PubMed - indexed for MEDLINE]
Free Article
16.

Allogeneic transplantation with reduced-intensity conditioning for Hodgkin and non-Hodgkin lymphoma: importance of histology for outcome.

Armand P, Kim HT, Ho VT, Cutler CS, Koreth J, Antin JH, LaCasce AS, Jacobsen ED, Fisher DC, Brown JR, Canellos GP, Freedman AS, Soiffer RJ, Alyea EP.

Biol Blood Marrow Transplant. 2008 Apr;14(4):418-25. doi: 10.1016/j.bbmt.2008.01.008.

PMID:
18342784
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Relapsed and refractory Hodgkin's lymphoma: new avenues?

Canellos GP.

Hematol Oncol Clin North Am. 2007 Oct;21(5):929-41. Review. Erratum in: Hematol Oncol Clin North Am. 2008 Aug;22(4):xi. Dosage error in article text.

PMID:
17908629
[PubMed - indexed for MEDLINE]
18.

Single agent bortezomib in the treatment of relapsed and refractory Hodgkin lymphoma: cancer and leukemia Group B protocol 50206.

Blum KA, Johnson JL, Niedzwiecki D, Canellos GP, Cheson BD, Bartlett NL.

Leuk Lymphoma. 2007 Jul;48(7):1313-9.

PMID:
17613759
[PubMed - indexed for MEDLINE]
19.

High dose CHOP: a phase II study of initial treatment in aggressive non-Hodgkin lymphoma. Cancer and Leukemia Group B 9351.

Peterson BA, Johnson J, Shipp MA, Barcos M, Gockerman JP, Canellos GP; Cancer and Leukemia Group B 9351.

Leuk Lymphoma. 2007 May;48(5):870-80.

PMID:
17487729
[PubMed - indexed for MEDLINE]
20.

Gemcitabine, vinorelbine, and pegylated liposomal doxorubicin (GVD), a salvage regimen in relapsed Hodgkin's lymphoma: CALGB 59804.

Bartlett NL, Niedzwiecki D, Johnson JL, Friedberg JW, Johnson KB, van Besien K, Zelenetz AD, Cheson BD, Canellos GP; Cancer Leukemia Group B.

Ann Oncol. 2007 Jun;18(6):1071-9. Epub 2007 Apr 10.

PMID:
17426059
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk